A detailed history of Tyche Wealth Partners LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Tyche Wealth Partners LLC holds 3,365 shares of NVO stock, worth $294,942. This represents 0.09% of its overall portfolio holdings.

Number of Shares
3,365
Previous 6,386 47.31%
Holding current value
$294,942
Previous $912 Million 56.04%
% of portfolio
0.09%
Previous 0.22%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 25, 2024

SELL
$119.07 - $145.42 $359,710 - $439,313
-3,021 Reduced 47.31%
3,365 $401 Million
Q2 2024

Jul 18, 2024

BUY
$122.71 - $146.91 $74,484 - $89,174
607 Added 10.5%
6,386 $912 Million
Q1 2024

Apr 23, 2024

BUY
$102.11 - $135.92 $590,093 - $785,481
5,779 New
5,779 $742 Million

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $198B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Tyche Wealth Partners LLC Portfolio

Follow Tyche Wealth Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tyche Wealth Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Tyche Wealth Partners LLC with notifications on news.